Add to ORKGTransgenic manipulation of intracellular signaling pathways may be an effective and highly-specific means of modifying cardiac conduction and slowing heart rate during atrial fibrillation. Is it time to consider gene therapy as an approach to managing atrial tachyarrhythmias
Due to the spectacular progress made in human genomic studies, molecular biology and genetics have b...
Cardiac disease is the leading cause of death in the developed world. Ventricular arrhythmias associ...
Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and...
Atrial fibrillation is the most common clinically significant cardiac arrhythmia, increasing the ris...
Gene therapy to treat electrical dysfunction of the heart is an appealing strategy because of the li...
Gene therapy has progressed from a dream to a bedside reality in quite a few human diseases. From i...
Bradycardia arising from pacemaker dysfunction can be debilitating and life threatening. Electronic ...
Despite the ongoing advances in pharmacology, devices and surgical approaches to treat heart rhythm ...
The morbidity and mortality of cardiac arrhythmias are major international health concerns. Drug and...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Gene therapy−dependent mod...
Introduction: Arrhythmias can cause symptoms ranging from simple dizziness to life-threatening circu...
Atrial fibrillation (AF) is a common cardiac disease with high prevalence in the general population....
Background: In cardiac gene therapy to improve contractile function, achieving gene expression in th...
Gene therapy is a promising modality for the treatment of inherited and acquired cardiovascular dise...
Cardiac arrhythmias remain a common challenge and are associated with significant morbidity and mort...
Due to the spectacular progress made in human genomic studies, molecular biology and genetics have b...
Cardiac disease is the leading cause of death in the developed world. Ventricular arrhythmias associ...
Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and...
Atrial fibrillation is the most common clinically significant cardiac arrhythmia, increasing the ris...
Gene therapy to treat electrical dysfunction of the heart is an appealing strategy because of the li...
Gene therapy has progressed from a dream to a bedside reality in quite a few human diseases. From i...
Bradycardia arising from pacemaker dysfunction can be debilitating and life threatening. Electronic ...
Despite the ongoing advances in pharmacology, devices and surgical approaches to treat heart rhythm ...
The morbidity and mortality of cardiac arrhythmias are major international health concerns. Drug and...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Gene therapy−dependent mod...
Introduction: Arrhythmias can cause symptoms ranging from simple dizziness to life-threatening circu...
Atrial fibrillation (AF) is a common cardiac disease with high prevalence in the general population....
Background: In cardiac gene therapy to improve contractile function, achieving gene expression in th...
Gene therapy is a promising modality for the treatment of inherited and acquired cardiovascular dise...
Cardiac arrhythmias remain a common challenge and are associated with significant morbidity and mort...
Due to the spectacular progress made in human genomic studies, molecular biology and genetics have b...
Cardiac disease is the leading cause of death in the developed world. Ventricular arrhythmias associ...
Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and...